Novo Nordisk A/S
Devices & Delivery Solutions
Alisan Atvur is principal UX researcher and design thinking catalyst at Novo Nordisk A/S in Denmark. His work focuses on using design to improve the quality of life (QoL) for people living with chronic diseases. His work has influenced Fortune 100 companies in finance, consumer electronics, IOT, and retail strategy. He periodically gives workshops and keynote lectures at international conferences and universities.

Presenter of 1 Presentation

FOUNDATIONAL USER EXPERIENCE NEEDS FOR NEWLY-DIAGNOSED PEOPLE WITH T2 DIABETES

Session Type
Virtual Oral Presentations Session
Date
Fri, 29.04.2022
Session Time
16:30 - 18:00
Room
Virtual Hall 1.1
Lecture Time
17:02 - 17:10

Abstract

Background and Aims

Initiating onto an injectable diabetes treatment can be met with resistance, concerns, and misconceptions by end users (2009, Rubin et al., 2014, Brod et al.). Without addressing these issues, patients may reject or discontinue their treatment (Atvur, 2021).

Methods

We performed thematic analysis of qualitative and quantitative research regarding the lived experiences of people on injectable therapies for T2 diabetes. We synthesized findings relating to end user concerns, desires, and expectations in order to form a list of “jobs-to-be-done” for a successful solution (2016, Chistensen et al.)

Results

This analysis uncovered >70 jobs-to-be-done, constraints, and outcome expectations people initiating on injectable therapy may experience. These findings were organized into 5 UX criteria which can be used for improving system design decisions for T2 treatment solutions.

Conclusions

The resulting 5 UX criteria can be used to inform foundational design and systems development activities towards a more user-centred T2 treatment solution.

Hide